Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
just a slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (just a slightly sore arm) in a 79-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. No Medical History information was reported. In September 2024, the patient received seventh dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form. In September 2024, the patient experienced PAIN IN EXTREMITY (just a slightly sore arm). At the time of the report, PAIN IN EXTREMITY (just a slightly sore arm) outcome was unknown. No concomitant medication was reported. It was stated patient developed reactions after getting a dose from Moderna COVID-19 vaccines. It was stated patient received Moderna COVID-19 vaccine since 2021. It was stated that the reaction on her first dose in February 2021 was a "minor rash" which was stated that was not so bad." In contrast to her 2nd dose in March 2021 which was stated to be a "major reaction". It was stated that in March 2021, patient got a whole torso body rash" and described the rash as "major rash" which lasted for 1 week. It was also added along with the rash that patient had sore arm, chills, and a low-grade fever. It was also narrated that she also received a dose in November 2021 which stated to experienced low grade fever that lasted for few hours and a minor rash for a couple of days. It was added that she also received a dose in September 2023 wherein she experienced 2 days of general lethargy, achy legs, and a rash that stayed for about a week. Lastly, the patient also received a dose in September 2024 wherein she experienced just a slightly sore arm. It was unknown if the patient experienced any additional symptoms/events. No treatment information was reported. This case was linked to MOD-2025-789700 (Patient Link).